Awards & Advancement

Fortress Biotech appoints Lucy Lu, MD, president and chief executive officer of Avenue Therapeutics

Wednesday, July 5, 2017

Fortress Biotech, Inc., a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, announced that Lucy Lu, MD, has been named President and Chief Executive Officer of its Fortress subsidiary Avenue Therapeutics, Inc. Dr. Lu has served as interim Chief Executive Officer of Avenue since inception. Fortress also announced that Ms. Robyn Hunter has been appointed Chief Financial Officer of Fortress, a role formerly held by Dr. Lu.

[Read More]

Akili adds executives to advance digital medicine product portfolio

Monday, July 3, 2017

Akili Interactive Labs announced the appointment of former Cubist Pharmaceuticals CEO, Robert J. Perez, as executive chairman. Perez has been a commercial advisor with the company for the past year and will now be joining in the more official leadership role as the company continues its growth. Additionally, the company has added former DreamWorks Interactive CEO, Glenn Entis, and former chief game designer at Google, Noah Falstein, as executive advisors.

[Read More]

Parexel again named to Forbes America’s Best Employers List

Thursday, June 29, 2017

Parexel International, a global biopharmaceutical services organization, announced that for the second year in a row, Forbes has named the company to its America’s “Best Employers” list. The list recognizes the top 300 midsized employers and top 500 large employers. Results are based on anonymous survey responses from 30,000 U.S. employees, with the most weighted factor being how likely they were to recommend their organizations to others.

[Read More]

WCG recognized for clinical trial awareness and education support

Wednesday, June 28, 2017

The Center for Information and Study on Clinical Research Participation (CISCRP), an independent, nonprofit organization dedicated to educating patients and the public about clinical research, is pleased to thank and recognize WIRB-Copernicus Group (WCG) for its recent support of CISCRP’s Medical Heroes 5K Run & Walk, held last week in Chicago, and its additional donation to CISCRP’s clinical research education and outreach programs.

[Read More]